BLATT LAWRENCE 4
4 · Aligos Therapeutics, Inc. · Filed Mar 4, 2025
Insider Transaction Report
Form 4
BLATT LAWRENCE
DirectorPresident and CEO
Transactions
- Award
Stock Option (Right to Buy)
2025-02-28+140,103→ 140,103 totalExercise: $16.87Exp: 2035-02-28→ Common Stock (140,103 underlying)
Footnotes (1)
- [F1]1/48th of the total number of shares vest in forty-eight (48) successive and equal monthly installments measured from February 28, 2025 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service through each vesting date.